Evaluation of Chemical Venous Thromboembolism Prophylaxis in Trauma
Condition:   Thromboembolism, Venous Intervention:   Drug: enoxaparin Sponsor:   Methodist Health System Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2023 Category: Research Source Type: clinical trials

Evaluation of Tolerance and Pharmacokinetic Profile of High Doses of Favipiravir in Healthy Volunteers
Conditions:   Infectious Disease;   Pharmacology Interventions:   Drug: favipiravir;   Drug: Placebo Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   FUJIFILM Toyama Chemical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2023 Category: Research Source Type: clinical trials

Evaluation of Chemical Venous Thromboembolism Prophylaxis in Trauma
Condition:   Thromboembolism, Venous Intervention:   Drug: enoxaparin Sponsor:   Methodist Health System Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2023 Category: Research Source Type: clinical trials

Evaluation of Tolerance and Pharmacokinetic Profile of High Doses of Favipiravir in Healthy Volunteers
Conditions:   Infectious Disease;   Pharmacology Interventions:   Drug: favipiravir;   Drug: Placebo Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   FUJIFILM Toyama Chemical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2023 Category: Research Source Type: clinical trials

Evaluation of Chemical Venous Thromboembolism Prophylaxis in Trauma
Condition:   Thromboembolism, Venous Intervention:   Drug: enoxaparin Sponsor:   Methodist Health System Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2023 Category: Research Source Type: clinical trials

Evaluation of Tolerance and Pharmacokinetic Profile of High Doses of Favipiravir in Healthy Volunteers
Conditions:   Infectious Disease;   Pharmacology Interventions:   Drug: favipiravir;   Drug: Placebo Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   FUJIFILM Toyama Chemical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2023 Category: Research Source Type: clinical trials

Evaluation of Chemical Venous Thromboembolism Prophylaxis in Trauma
Condition:   Thromboembolism, Venous Intervention:   Drug: enoxaparin Sponsor:   Methodist Health System Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2023 Category: Research Source Type: clinical trials

Evaluation of Tolerance and Pharmacokinetic Profile of High Doses of Favipiravir in Healthy Volunteers
Conditions:   Infectious Disease;   Pharmacology Interventions:   Drug: favipiravir;   Drug: Placebo Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   FUJIFILM Toyama Chemical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2023 Category: Research Source Type: clinical trials

Evaluation of Chemical Venous Thromboembolism Prophylaxis in Trauma
Condition:   Thromboembolism, Venous Intervention:   Drug: enoxaparin Sponsor:   Methodist Health System Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2023 Category: Research Source Type: clinical trials